Uroquinase (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Uroquinase" in Galician language version.

refsWebsite

Global rank Galician rank

4^th place

6^th place

2^nd place

7^th place

6^th place

8^th place

5,225^th place

7,257^th place

low place

low place

archive.org

Degryse, Bernard (1 June 2011). "The urokinase receptor system as strategic therapeutic target: challenges for the 21st century". Current Pharmaceutical Design 17 (19): 1872–1873. doi:10.2174/138161211796718161.
Tang, Linlin; Han, Xiuzhen (March 2013). "The urokinase plasminogen activator system in breast cancer invasion and metastasis". Biomedicine & Pharmacotherapy 67 (2): 179–182. doi:10.1016/j.biopha.2012.10.003.
Nagai M, Hiramatsu R, Kanéda T, Hayasuke N, Arimura H, Nishida M, Suyama T (Dec 1985). "Molecular cloning of cDNA coding for human preprourokinase". Gene 36 (1-2): 183–8. PMID 2415429. doi:10.1016/0378-1119(85)90084-8.
España F, Berrettini M, Griffin JH (Aug 1989). "Purification and characterization of plasma protein C inhibitor". Thromb. Res. 55 (3): 369–84. PMID 2551064. doi:10.1016/0049-3848(89)90069-8.
Matthews H, Ranson M, Kelso MJ (November 2011). "Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?". Int. J. Cancer 129 (9): 2051–61. PMID 21544803. doi:10.1002/ijc.26156.

Nagai M, Hiramatsu R, Kanéda T, Hayasuke N, Arimura H, Nishida M, Suyama T (Dec 1985). "Molecular cloning of cDNA coding for human preprourokinase". Gene 36 (1-2): 183–8. PMID 2415429. doi:10.1016/0378-1119(85)90084-8.
"Entrez Gene: PLAU plasminogen activator, urokinase".
Geiger M, Huber K, Wojta J, Stingl L, Espana F, Griffin JH, Binder BR (Aug 1989). "Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo". Blood 74 (2): 722–8. PMID 2752144.
España F, Berrettini M, Griffin JH (Aug 1989). "Purification and characterization of plasma protein C inhibitor". Thromb. Res. 55 (3): 369–84. PMID 2551064. doi:10.1016/0049-3848(89)90069-8.
Jankun J, Skrzypczak-Jankun E (July 1999). "Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride". Cancer Biochem. Biophys. 17 (1-2): 109–23. PMID 10738907.
Matthews H, Ranson M, Kelso MJ (November 2011). "Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?". Int. J. Cancer 129 (9): 2051–61. PMID 21544803. doi:10.1002/ijc.26156.